Expression of receptor protein tyrosine kinase tif is regulated during leukemia cell differentiation.
tif is a recently cloned and characterized cDNA predicting a transmembrane protein with a putative tyrosine kinase structure in its cytoplasmic domain. By analysis of the purified tif cytoplasmic domain expressed in Escherichia coli, we have demonstrated that tif is an active protein tyrosine kinase capable of autophosphorylation on tyrosine residues and this phosphorylation is inhibited by a tyrosine-specific inhibitor genistein. Northern blot analyses of various leukemia cell lines have revealed that tif mRNA expression is primarily confined to those bearing erythroid and megakaryocytic phenotypes. Megakaryocytic differentiation of K562 and HEL cells induced by phorbol 12-myristate 13-acetate is accompanied by down-regulation of tif mRNA expression. In addition, treatment of K562 and HEL with hexamethylene bis-acetamide, but not with hemin, decreases the steady-state level of tif mRNA. These combined results suggest that the receptor tyrosine kinase tif is involved in hematopoietic development.
Dai
W
W
Department of Internal Medicine, University of Cincinnati College of Medicine, OH 45267-0508, USA.
Pan
H Q
HQ
Ouyang
B
B
Greenberg
J M
JM
Means
R T
RT
Li
B
B
Cardie
J
J
D000081:Acetamides / Q000494:pharmacology; D001483:Base Sequence; D002454:Cell Differentiation / Q000187:drug effects; D015536:Down-Regulation; D015971:Gene Expression Regulation, Enzymologic; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D007938:Leukemia / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D004915:Leukemia, Erythroblastic, Acute / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D007947:Leukemia, Megakaryoblastic, Acute / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D008969:Molecular Sequence Data; D010766:Phosphorylation; D012333:RNA, Messenger / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology
D000081:Acetamides; D012333:RNA, Messenger; D020794:Receptor Protein-Tyrosine Kinases; C014026:hexamethylene bisacetamide; D013755:Tetradecanoylphorbol Acetate